Is Xtampza ER a controlled substance?
Yes. Xtampza ER (oxycodone) is a schedule II controlled substance.
What is Xtampza ER?
Xtampza ER (oxycodone) an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Xtampza ER is an extended-release, abuse-deterrent formulation of oxycodone for twice-daily administration.
What is a Schedule II Controlled Substance?
Drugs placed in Schedule II of the Controlled Substances Act (CSA) have a high potential for abuse and dependence.
Drugs in Schedule II have a currently accepted medical use in the United States or a currently accepted medical use with severe restrictions. Abuse of these drugs may lead to severe psychological or physical dependence.
Examples of Schedule II substances include morphine, cocaine, hydrocodone, oxycodone, fentanyl, and methylphenidate.
What does Abuse-Deterrent mean?
Xtampza ER uses the proprietary DETERx® technology platform to prevent abuse of the active ingredient oxycodone. It is designed to prevent abuse by maintaining the drug release profile even after physical manipulation including chewing and crushing/dissolving. Misuse of Xtampza ER can lead to overdose and death.
Related medical questions
- Which painkiller should you use?
- Oxycodone vs Hydrocodone - How do they compare?
- What is hydrochloride?
- How long does opioid withdrawal last?
- Oxycodone vs OxyContin - What's the difference?
- Xtampza ER Information for Consumers
- Xtampza ER Information for Healthcare Professionals (includes dosage details)
- Side Effects of Xtampza ER (detailed)